Induction of intestinal epithelial proliferation by glucagon-like peptide 2. DJ Drucker, P Erlich, SL Asa, PL Brubaker Proceedings of the National Academy of Sciences 93 (15), 7911-7916, 1996 | 1041 | 1996 |
Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene LA Scrocchi, TJ Brown, N MaClusky, PL Brubaker, AB Auerbach, ... Nature medicine 2 (11), 1254-1258, 1996 | 950 | 1996 |
Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system PL Brubaker, DJ Drucker Endocrinology 145 (6), 2653-2659, 2004 | 722 | 2004 |
Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion AS Rocca, PL Brubaker Endocrinology 140 (4), 1687-1694, 1999 | 634 | 1999 |
TCF-4 mediates cell type-specific regulation of proglucagon gene expression by β-catenin and glycogen synthase kinase-3β F Yi, PL Brubaker, T Jin Journal of Biological Chemistry 280 (2), 1457-1464, 2005 | 560 | 2005 |
Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice Q Wang, P Brubaker Diabetologia 45, 1263-1273, 2002 | 441 | 2002 |
GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell LM Lauffer, R Iakoubov, PL Brubaker Diabetes 58 (5), 1058-1066, 2009 | 431 | 2009 |
Intestinal growth-promoting properties of glucagon-like peptide-2 in mice CH Tsai, M Hill, SL Asa, PL Brubaker, DJ Drucker American Journal of Physiology-Endocrinology and Metabolism 273 (1), E77-E84, 1997 | 428 | 1997 |
Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency RS Jackson, JWM Creemers, IS Farooqi, ML Raffin-Sanson, A Varro, ... The Journal of clinical investigation 112 (10), 1550-1560, 2003 | 411 | 2003 |
Role of leptin in the regulation of glucagon-like peptide-1 secretion Y Anini, PL Brubaker Diabetes 52 (2), 252-259, 2003 | 371 | 2003 |
Peripheral Exendin-4 and Peptide YY3–36 Synergistically Reduce Food Intake through Different Mechanisms in Mice T Talsania, Y Anini, S Siu, DJ Drucker, PL Brubaker Endocrinology 146 (9), 3748-3756, 2005 | 366 | 2005 |
Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop JN Roberge, PL Brubaker Endocrinology 133 (1), 233-240, 1993 | 354 | 1993 |
β-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1 Y Li, X Cao, LX Li, PL Brubaker, H Edlund, DJ Drucker Diabetes 54 (2), 482-491, 2005 | 347 | 2005 |
Role of prohormone convertases in the tissue-specific processing of proglucagon. S Dhanvantari, NG Seidah, PL Brubaker Molecular endocrinology 10 (4), 342-355, 1996 | 340 | 1996 |
Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line. DJ Drucker, T Jin, SL Asa, TA Young, PL Brubaker Molecular endocrinology 8 (12), 1646-1655, 1994 | 333 | 1994 |
Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2 PL Brubaker, A Izzo, M Hill, DJ Drucker American Journal of Physiology-Endocrinology And Metabolism 272 (6), E1050-E1058, 1997 | 321 | 1997 |
Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV D Drucker, Q Shi, A Crivici, M Sumner-Smith, W Tavares, M Hill, ... Nature Biotechnology 15 (7), 673-677, 1997 | 321 | 1997 |
Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans Q Xiao, RP Boushey, DJ Drucker, PL Brubaker Gastroenterology 117 (1), 99-105, 1999 | 294 | 1999 |
Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells Q Wang, L Li, E Xu, V Wong, C Rhodes, PL Brubaker Diabetologia 47, 478-487, 2004 | 289 | 2004 |
Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B L Li, W El-Kholy, CJ Rhodes, PL Brubaker Diabetologia 48, 1339-1349, 2005 | 285 | 2005 |